IDEAS home Printed from https://ideas.repec.org/a/epw/clinic/v2y2021i3id12096.html

A Case Series on Suspected Remdesivir Induced Hyperammonemia

Author

Listed:
  • Sagar R. Bhimani

    (Smt. NHL Municipal Medical College, India)

  • Sapna B. Gupta

    (Smt. NHL Municipal Medical College, India)

  • Kamlesh P. Patel

    (Smt. NHL Municipal Medical College, India)

  • Supriya D. Malhotra

    (Smt. NHL Municipal Medical College, India)

Abstract

Remdesivir is a broad spectrum anti-viral drug that has shown to inhibit SARS-CoV-2. In absence of any effective treatment for SARS-CoV-2 infection (COVID-19), Remdesivir has been tried for a compassionate use in severe COVID-19. Remdesivir has shown promise in the management of patients with COVID-19 although recent studies have shown concerns with its effectiveness and safety in practice. Despite this there is a need to document potential Adverse drug Reaction (ADR) to guide future decisions. We describe 2 cases of Suspected Remdesivir-induced hyperammonemia (SRIH) in patients with normal liver function. Serum ammonia levels was raised much above the baseline after a fortnight of therapy. After completion of the therapy, there was gradual improvement and normalization of serum ammonia levels. This suggested a causal relationship which was possibly due to the administration of Remdesivir drug. With the increasing use, physicians should be aware of this potential ADR of Remdesivir and evaluate ammonia levels in patients taking Remdesivir who present with alterations in mental status.

Suggested Citation

  • Sagar R. Bhimani & Sapna B. Gupta & Kamlesh P. Patel & Supriya D. Malhotra, 2021. "A Case Series on Suspected Remdesivir Induced Hyperammonemia," European Journal of Clinical Medicine, European Open Science, vol. 2(3), pages 8-10, June.
    • Handle: RePEc:epw:clinic:v:2:y:2021:i:3:id:12096
    DOI: 10.24018/clinicmed.2021.2.3.96
    as

    Download full text from publisher

    File URL: https://eu-opensci.org/index.php/clinicmed/article/view/12096
    File Function: Abstract page
    Download Restriction: no
    File URL: https://eu-opensci.org/index.php/clinicmed/article/download/12096/2380
    File Function: Full text
    Download Restriction: no
    File URL: https://libkey.io/10.24018/clinicmed.2021.2.3.96?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:clinic:v:2:y:2021:i:3:id:12096. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/clinicmed .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.